215 related articles for article (PubMed ID: 37591845)
1. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
John L; Poos AM; Brobeil A; Schinke C; Huhn S; Prokoph N; Lutz R; Wagner B; Zangari M; Tirier SM; Mallm JP; Schumacher S; Vonficht D; Solé-Boldo L; Quick S; Steiger S; Przybilla MJ; Bauer K; Baumann A; Hemmer S; Rehnitz C; Lückerath C; Sachpekidis C; Mechtersheimer G; Haberkorn U; Dimitrakopoulou-Strauss A; Reichert P; Barlogie B; Müller-Tidow C; Goldschmidt H; Hillengass J; Rasche L; Haas SF; van Rhee F; Rippe K; Raab MS; Sauer S; Weinhold N
Nat Commun; 2023 Aug; 14(1):5011. PubMed ID: 37591845
[TBL] [Abstract][Full Text] [Related]
2. Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Poos AM; Prokoph N; Przybilla MJ; Mallm JP; Steiger S; Seufert I; John L; Tirier SM; Bauer K; Baumann A; Rohleder J; Munawar U; Rasche L; Kortüm KM; Giesen N; Reichert P; Huhn S; Müller-Tidow C; Goldschmidt H; Stegle O; Raab MS; Rippe K; Weinhold N
Blood; 2023 Nov; 142(19):1633-1646. PubMed ID: 37390336
[TBL] [Abstract][Full Text] [Related]
3. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.
Rasche L; Chavan SS; Stephens OW; Patel PH; Tytarenko R; Ashby C; Bauer M; Stein C; Deshpande S; Wardell C; Buzder T; Molnar G; Zangari M; van Rhee F; Thanendrarajan S; Schinke C; Epstein J; Davies FE; Walker BA; Meissner T; Barlogie B; Morgan GJ; Weinhold N
Nat Commun; 2017 Aug; 8(1):268. PubMed ID: 28814763
[TBL] [Abstract][Full Text] [Related]
4. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
Ndacayisaba LJ; Rappard KE; Shishido SN; Ruiz Velasco C; Matsumoto N; Navarez R; Tang G; Lin P; Setayesh SM; Naghdloo A; Hsu CJ; Maney C; Symer D; Bethel K; Kelly K; Merchant A; Orlowski R; Hicks J; Mason J; Manasanch EE; Kuhn P
Curr Oncol; 2022 Apr; 29(5):2954-2972. PubMed ID: 35621632
[TBL] [Abstract][Full Text] [Related]
5. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
Dang M; Wang R; Lee HC; Patel KK; Becnel MR; Han G; Thomas SK; Hao D; Chu Y; Weber DM; Lin P; Lutter-Berka Z; Berrios Nolasco DA; Huang M; Bansal H; Song X; Zhang J; Futreal A; Moreno Rueda LY; Symer DE; Green MR; Rojas Hernandez CM; Kroll M; Afshar-Khargan V; Ndacayisaba LJ; Kuhn P; Neelapu SS; Orlowski RZ; Wang L; Manasanch EE
Cancer Cell; 2023 Jun; 41(6):1032-1047.e4. PubMed ID: 37311413
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
Ryu D; Kim SJ; Hong Y; Jo A; Kim N; Kim HJ; Lee HO; Kim K; Park WY
Clin Cancer Res; 2020 Feb; 26(4):935-944. PubMed ID: 31558476
[TBL] [Abstract][Full Text] [Related]
7. The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states.
Rasche L; Schinke C; Maura F; Bauer MA; Ashby C; Deshpande S; Poos AM; Zangari M; Thanendrarajan S; Davies FE; Walker BA; Barlogie B; Landgren O; Morgan GJ; van Rhee F; Weinhold N
Nat Commun; 2022 Aug; 13(1):4517. PubMed ID: 35922426
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis.
Yao L; Jayasinghe RG; Lee BH; Bhasin SS; Pilcher W; Doxie DB; Gonzalez-Kozlova E; Dasari S; Fiala MA; Pita-Juarez Y; Strausbauch M; Kelly G; Thomas BE; Kumar SK; Cho HJ; Anderson E; Wendl MC; Dawson T; D'souza D; Oh ST; Cheloni G; Li Y; DiPersio JF; Rahman AH; Dhodapkar KM; Kim-Schulze S; Vij R; Vlachos IS; Mehr S; Hamilton M; Auclair D; Kourelis T; Avigan D; Dhodapkar MV; Gnjatic S; Bhasin MK; Ding L
Cancer Res Commun; 2022 Oct; 2(10):1255-1265. PubMed ID: 36969740
[TBL] [Abstract][Full Text] [Related]
9. Molecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma.
Chakraborty C; Mukherjee S
Curr Oncol; 2022 Dec; 29(12):9535-9549. PubMed ID: 36547163
[TBL] [Abstract][Full Text] [Related]
10. Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma.
Barwick BG; Gupta VA; Matulis SM; Patton JC; Powell DR; Gu Y; Jaye DL; Conneely KN; Lin YC; Hofmeister CC; Nooka AK; Keats JJ; Lonial S; Vertino PM; Boise LH
Clin Cancer Res; 2021 Jun; 27(11):3178-3189. PubMed ID: 33731366
[TBL] [Abstract][Full Text] [Related]
11. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.
Tirier SM; Mallm JP; Steiger S; Poos AM; Awwad MHS; Giesen N; Casiraghi N; Susak H; Bauer K; Baumann A; John L; Seckinger A; Hose D; Müller-Tidow C; Goldschmidt H; Stegle O; Hundemer M; Weinhold N; Raab MS; Rippe K
Nat Commun; 2021 Nov; 12(1):6960. PubMed ID: 34845188
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma.
He H; Li Z; Lu J; Qiang W; Jiang S; Xu Y; Fu W; Zhai X; Zhou L; Qian M; Du J
Clin Transl Med; 2022 Mar; 12(3):e757. PubMed ID: 35297204
[TBL] [Abstract][Full Text] [Related]
13. Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses.
Yao Q; Morgan GJ; Chim CS
Clin Epigenetics; 2018 Dec; 10(1):158. PubMed ID: 30572945
[TBL] [Abstract][Full Text] [Related]
14. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.
Fan J; Lee HO; Lee S; Ryu DE; Lee S; Xue C; Kim SJ; Kim K; Barkas N; Park PJ; Park WY; Kharchenko PV
Genome Res; 2018 Aug; 28(8):1217-1227. PubMed ID: 29898899
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
Groen RW; de Rooij MF; Kocemba KA; Reijmers RM; de Haan-Kramer A; Overdijk MB; Aalders L; Rozemuller H; Martens AC; Bergsagel PL; Kersten MJ; Pals ST; Spaargaren M
Haematologica; 2011 Nov; 96(11):1653-61. PubMed ID: 21828122
[TBL] [Abstract][Full Text] [Related]
16. Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma.
Merz M; Merz AMA; Wang J; Wei L; Hu Q; Hutson N; Rondeau C; Celotto K; Belal A; Alberico R; Block AW; Mohammadpour H; Wallace PK; Tario J; Luce J; Glenn ST; Singh P; Herr MM; Hahn T; Samur M; Munshi N; Liu S; McCarthy PL; Hillengass J
Nat Commun; 2022 Feb; 13(1):807. PubMed ID: 35145077
[TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.
Zavidij O; Haradhvala NJ; Mouhieddine TH; Sklavenitis-Pistofidis R; Cai S; Reidy M; Rahmat M; Flaifel A; Ferland B; Su NK; Agius MP; Park J; Manier S; Bustoros M; Huynh D; Capelletti M; Berrios B; Liu CJ; He MX; Braggio E; Fonseca R; Maruvka YE; Guerriero JL; Goldman M; Van Allen EM; McCarroll SA; Azzi J; Getz G; Ghobrial IM
Nat Cancer; 2020 May; 1(5):493-506. PubMed ID: 33409501
[TBL] [Abstract][Full Text] [Related]
18. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma.
Rasche L; Kortüm KM; Raab MS; Weinhold N
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871078
[TBL] [Abstract][Full Text] [Related]
20. Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM).
Zhong L; Hao P; Zhang Q; Jiang T; Li H; Xiao J; Li C; Luo L; Xie C; Hu J; Wang L; Liu Y; Shi Y; Zhang W; Gong B
Elife; 2022 Oct; 11():. PubMed ID: 36315425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
